Login / Signup

Thyroid-stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity.

Ville L LangénTeemu J NiiranenPauli PuukkaArttu O LehtonenJussi A HernesniemiJouko SundvallVeikko SalomaaAntti M Jula
Published in: Clinical endocrinology (2017)
Thyroid function abnormalities could be linked with higher risks of total mortality and SCD. Large-scale randomized studies are needed for evidence-based recommendations regarding treatment of mild thyroid failure.
Keyphrases
  • cardiovascular events
  • risk factors
  • open label
  • double blind
  • randomized controlled trial
  • clinical trial
  • phase iii
  • coronary artery disease
  • combination therapy